These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 33731148)

  • 1. Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms.
    Halyabar O; Friedman KG; Sundel RP; Baker AL; Chang MH; Gould PW; Newburger JW; Son MBF
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):31. PubMed ID: 33731148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
    Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.
    Friedman KG; Gauvreau K; Hamaoka-Okamoto A; Tang A; Berry E; Tremoulet AH; Mahavadi VS; Baker A; deFerranti SD; Fulton DR; Burns JC; Newburger JW
    J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27633390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis.
    Miyata K; Bainto EV; Sun X; Jain S; Dummer KB; Burns JC; Tremoulet AH
    Arch Dis Child; 2023 Oct; 108(10):833-838. PubMed ID: 37258054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retrospective analysis of infliximab in the treatment of Kawasaki disease].
    Xie LP; Zhao L; Chu C; He L; Liang XC; Sun SN; Zhao QM; Wang F; Cao YY; Lin YX; Zeng ZQ; Wu L; Huang GY; Liu F
    Zhonghua Er Ke Za Zhi; 2022 Jan; 60(1):14-19. PubMed ID: 34986617
    [No Abstract]   [Full Text] [Related]  

  • 6. [Kawasaki disease in children--9 years experience].
    Kowalczyk M; Kawalec W; Daszkowska-York J; Turska-Kmieć A; Brzezińska-Rajszys G; Sobielarska D; Ziółkowska L; Kościesza A; Jagiełłowicz D; Mirecka-Rola A
    Med Wieku Rozwoj; 2005; 9(2):179-93. PubMed ID: 16085959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis.
    Dionne A; Burns JC; Dahdah N; Tremoulet AH; Gauvreau K; de Ferranti SD; Baker AL; Son MB; Gould P; Fournier A; Newburger JW; Friedman KG
    Pediatrics; 2019 Jun; 143(6):. PubMed ID: 31048414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis.
    Friedman KG; Gauvreau K; Baker A; Son MB; Sundel R; Dionne A; Giorgio T; De Ferranti S; Newburger JW
    Arch Dis Child; 2021 Mar; 106(3):247-252. PubMed ID: 32943389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events.
    Miura M; Kobayashi T; Kaneko T; Ayusawa M; Fukazawa R; Fukushima N; Fuse S; Hamaoka K; Hirono K; Kato T; Mitani Y; Sato S; Shimoyama S; Shiono J; Suda K; Suzuki H; Maeda J; Waki K; ; Kato H; Saji T; Yamagishi H; Ozeki A; Tomotsune M; Yoshida M; Akazawa Y; Aso K; Doi S; Fukasawa Y; Furuno K; Hayabuchi Y; Hayashi M; Honda T; Horita N; Ikeda K; Ishii M; Iwashima S; Kamada M; Kaneko M; Katyama H; Kawamura Y; Kitagawa A; Komori A; Kuraishi K; Masuda H; Matsuda S; Matsuzaki S; Mii S; Miyamoto T; Moritou Y; Motoki N; Nagumo K; Nakamura T; Nishihara E; Nomura Y; Ogata S; Ohashi H; Okumura K; Omori D; Sano T; Suganuma E; Takahashi T; Takatsuki S; Takeda A; Terai M; Toyono M; Watanabe K; Watanabe M; Yamamoto M; Yamamura K
    JAMA Pediatr; 2018 May; 172(5):e180030. PubMed ID: 29507955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Giant aneurysms: A gender-specific complication of Kawasaki disease?
    Dietz SM; Kuipers IM; Tacke CEA; Koole JCD; Hutten BA; Kuijpers TW
    J Cardiol; 2017 Oct; 70(4):359-365. PubMed ID: 28325522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A registry study of Kawasaki disease patients with coronary artery aneurysms (KIDCAR): a report on a multicenter prospective registry study three years after commencement.
    Koyama Y; Miura M; Kobayashi T; Hokosaki T; Suganuma E; Numano F; Furuno K; Shiono J; Ebata R; Fuse S; Fukazawa R; Mitani Y
    Eur J Pediatr; 2023 Feb; 182(2):633-640. PubMed ID: 36434403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood routine risk factors for coronary artery aneurysm in infants younger than 8 months with Kawasaki disease.
    Haiyan G; Jianming L; Suqian T; Dong Q; Shuang L; Jin Z
    BMC Pediatr; 2022 Jan; 22(1):29. PubMed ID: 34996405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-coronary cardiac events, younger age, and IVIG unresponsiveness increase the risk for coronary aneurysms in Italian children with Kawasaki disease.
    Fabi M; Andreozzi L; Frabboni I; Dormi A; Corinaldesi E; Lami F; Cicero C; Tchana B; Francavilla R; Sprocati M; Bigucci B; Balsamo C; Valin PS; Di Fazzio G; Iughetti L; Valletta E; Marchetti F; Donti A; Lanari M
    Clin Rheumatol; 2021 Apr; 40(4):1507-1514. PubMed ID: 32936425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and Risk Factors for Giant Coronary Artery Aneurysms Identified After Acute Kawasaki Disease.
    Masuda H; Ae R; Koshimizu TA; Matsumura M; Kosami K; Hayashida K; Makino N; Matsubara Y; Sasahara T; Nakamura Y
    Pediatr Cardiol; 2021 Apr; 42(4):969-977. PubMed ID: 33682062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Harada score in the US population of children with Kawasaki disease.
    Tewelde H; Yoon J; Van Ittersum W; Worley S; Preminger T; Goldfarb J
    Hosp Pediatr; 2014 Jul; 4(4):233-8. PubMed ID: 24986993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High risk of coronary artery aneurysm in Kawasaki disease.
    Mossberg M; Mohammad AJ; Kahn F; Segelmark M; Kahn R
    Rheumatology (Oxford); 2021 Apr; 60(4):1910-1914. PubMed ID: 33150451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anakinra Treatment in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysms: A Phase I/IIa Trial.
    Yang J; Jain S; Capparelli EV; Best BM; Son MB; Baker A; Newburger JW; Franco A; Printz BF; He F; Shimizu C; Hoshino S; Bainto E; Moreno E; Pancheri J; Burns JC; Tremoulet AH
    J Pediatr; 2022 Apr; 243():173-180.e8. PubMed ID: 34953816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary artery aneurysm regression after Kawasaki disease and associated risk factors: a 3-year follow-up study in East China.
    Tang Y; Yan W; Sun L; Xu Q; Ding Y; Lv H
    Clin Rheumatol; 2018 Jul; 37(7):1945-1951. PubMed ID: 29330741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial).
    Tremoulet AH; Jain S; Kim S; Newburger J; Arditi M; Franco A; Best B; Burns JC
    Contemp Clin Trials; 2016 May; 48():70-5. PubMed ID: 27080929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kawasaki disease in infants less than one year of age.
    Rosenfeld EA; Corydon KE; Shulman ST
    J Pediatr; 1995 Apr; 126(4):524-9. PubMed ID: 7699529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.